C-MER Medical Holdings Limited (3309.HK)
- Previous Close
1.710 - Open
1.710 - Bid 1.710 x --
- Ask 1.720 x --
- Day's Range
1.700 - 1.730 - 52 Week Range
1.330 - 3.280 - Volume
744,000 - Avg. Volume
2,048,398 - Market Cap (intraday)
2.135B - Beta (5Y Monthly) 0.78
- PE Ratio (TTM)
-- - EPS (TTM)
-0.110 - Earnings Date Mar 21, 2025
- Forward Dividend & Yield 0.02 (1.16%)
- Ex-Dividend Date Jun 27, 2025
- 1y Target Est
--
C-MER Medical Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. It operates through five segments: HK Medical Business, Sales of Medical Consumables, Mainland China Ophthalmic Business, Mainland China Dental Business, and Mainland China other business. The company provides oncology, medical aesthetics, general practice, ophthalmic, dental, and other medical services; cataract, glaucoma, strabismus and refractive surgeries, external eye diseases, and vitreoretinal disease services; and medical consumables. It also engages in the sale of vision aid products, such as glasses and lens. The company was formerly known as C-MER Eye Care Holdings Limited and changed its name to C-MER Medical Holdings Limited in June 2024. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Medical Holdings Limited is a subsidiary of C-MER Group Limited.
www.cmermedical.com2,041
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 3309.HK
View MorePerformance Overview: 3309.HK
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 3309.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 3309.HK
View MoreValuation Measures
Market Cap
2.13B
Enterprise Value
2.11B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.12
Price/Book (mrq)
1.22
Enterprise Value/Revenue
1.10
Enterprise Value/EBITDA
7.55
Financial Highlights
Profitability and Income Statement
Profit Margin
-7.07%
Return on Assets (ttm)
2.95%
Return on Equity (ttm)
-5.58%
Revenue (ttm)
1.91B
Net Income Avi to Common (ttm)
-135.16M
Diluted EPS (ttm)
-0.110
Balance Sheet and Cash Flow
Total Cash (mrq)
467.25M
Total Debt/Equity (mrq)
23.17%
Levered Free Cash Flow (ttm)
107.98M